What better way to describe the event than a comment from our Keynote speaker and Industry Leader, John Hubbard:

“I was recently invited to be a Keynote Speaker and Panelist at the PCMG Conference in Barcelona.  It was an incredible event, very different from other conferences I have attended in the past, there are no exhibits.  The members are the pharmaceutical contract management group and include both pharmaceutical and CRO representatives.  They are oriented toward open, candid and constructive conversations with a focus on improving the interface between biopharmaceutical sponsors and CROs.  I could feel the positive energy to collaborate and solve problems from the PCMG members.”

 

PCMG’s unique conference format returned for the 15th year and PCMG celebrates its 25th Year. The Joint Committee of PCMG and CRO members set its sights on a range of key challenges to achieving mutual outsourcing goals developing and delivering another incredible program including….
  • Assessment of rapidly evolving Regulatory, Technology and Finance impact on outsourcing – A strategic early-warning
  • The realities of outsourcing studies with Academia – Are you really prepared?
  • Real-world pharma implementation of quality, speed and value outsourcing strategy – The how-to and how-not-to of outsourcing strategies
  • Big Data theory in outsourcing practice – what does it mean and what does it change?
  • Lessons in outsourcing Medical Device studies – do you know what’s the same and what’s different?
  • Good Idea/Bad Idea interactive forum to target best and worst practice to take home (or not).
  • Are we there yet? The latest from months of preparation, estimation and worst-case scenarios of Brexit’s impact
  • Japan’s growth in clinical trials – understanding the facts of running outsourced studies in Japan
  • Cost vs. benefit of ‘Patient Centricity’ –nice to have or need to have?
  • PCMG’s thought-provoking out-of-industry perspective session from the defence sector: Outsourcing with Lives at Stake

Hotel Melia, Sitges. Everybody under the one roof, sharing networking opportunities - not scattered across hotels and private dining events!
Speaker list included
  • John Hubbard Genstar Capital Strategic Advisor Board Member and former CEO Bioclinca, Global Clinops Leader, Pfizer & CEO ICON
  • Bill Burns Non-Exec Director, Shire Pharma, Wellcome Trust Governor & former CEO, Roche Pharma
  • Ludo Reynders CEO, Premier Research Inc. & former Quintiles Executive
  • Rich Butterworth Senior Director Alliance Mgt. Merck Group
  • Chris Clare VP Quality, Labcorp-Covance
  • Frances Kendall Senior Director Biostatistics & Programming, Cytel
  • Rob Aitchison Head of Outsourcing & Contracts, Ono Pharma
  • Pam Turner, QP, Geyron Pharma
  • Prof. Trevor Taylor Royal United Services Institute UK
  • Dan Feldman VP Asia Pacific, Medpace, Singapore

See the program for full listing!

Related Events